AAO: IRIS registry recognized by CMS
The American Academy of Ophthalmology announced that its longitudinal eye disease and condition database, the Intelligent Research in Sight Registry, has been recognized by the Centers for Medicare and Medicaid Services as an approved method for enhanced federal quality reporting, according to a press release.
The Intelligent Research in Sight (IRIS) database — launched in March 2014 — has received two Physician Quality Reporting System designations: a qualified registry and a qualified clinical data registry.
“Securing these designations is a significant milestone for the medical specialty of ophthalmology,” William L. Rich III, MD, medical director of health policy for AAO, said in the press release. “Through the IRIS Registry, ophthalmology now has the power to design specialty-specific measures that will enhance the value of CMS quality reporting and help improve patient outcomes.”
The registry assists clinicians and surgeons by ensuring that practices comply with federal payment programs. It is also designed to help identify ways to improve quality care and practice efficiency, according to the release.
Subspecialty modules enable the registry to analyze preexisting conditions, risk factors, disease severity and demographics that may impact outcomes in age-related macular degeneration, cataract surgery, diabetic retinopathy and retinal surgery. The registry can also help reduce the cost and enhance the speed of some large clinical trials, the release stated.
Approximately 4,000 clinicians have already implemented the 7 million-patient-record registry, with an expectation for more than 20 million patient records to be added within 2 years.